##  [Development Hub in India](/in-en/about/development "Development Hub in India") 

 ### Our Development organization oversees the development of new medicines discovered by our researchers and partners.

This division is responsible for advancing our pipeline of investigational medicines, to bring transformative new treatment options to patients with serious diseases. It leads the clinical development of potential new medicines, running large clinical trials and generating evidence that turns molecules to medicines. It has key hubs in Switzerland (Basel), the USA (East Hanover) and India (Hyderabad and Mumbai).

The India hub has evolved over 20 years and today sees three vibrant state-of-the-art centres across two cities, Hyderabad - at the Novartis Corporate Center (NOCC) and Genome Valley, and a recent one in Mumbai. Today, the India hub is an important base to support the development journey of many breakthrough medicines across all therapy areas (cardiovascular, oncology, immunology, neurology and global health). The India center supports all global functions including Global Clinical Operations, Technical R&D, Patient Safety and Pharmacovigilance, Regulatory Affairs, Advanced Quantitative Sciences, to name a few.

**The vast footprint of the Development division in India (~2,400 employees) is instrumental in supporting the company’s long-term growth and delivering on its purpose to improve and extend people’s lives.**

For the last 12+ years, Novartis Technical R&D has been increasing its footprint in Genome Valley, Hyderabad and currently 350+ scientists including Masters, PhDs and post doctorates are supporting to the pharmaceutical development of new chemical entities.

As India is cementing its position as a destination of choice, the hub is providing impetus to bright leaders and also deepening its focus on drug development work. The Development Hub today\* has:



 



 52 

####  Active clinical trials 

 

 335 

####  Trial sites 

 

 ~2,000 

####  Patients enrolled 

 

 







\*Data as of July 2024

  
  var kPlayer = KalturaPlayer_55802022 || KalturaPlayer;
  var config = {
    targetId: "kaltura_player_6a88110ce9402300938092",
    provider: {
      widgetId: "1_b1qylbmz",
      partnerId: "2076321",
      uiConfId: "55802022"
    },
    playback: {
      autoplay: false,
      autopause: false,
      muted: false,
      loop: false    },
    sources: {
      options: {},
      startTime: 0
    },
    disableUserCache: "true",
    plugins: {},
    sources: {
      options: {},
      startTime: 0
    },
    ui: {
      showCCButton: false,
      settings: {
        showQualityMenu: true,
        showSpeedMenu: false      },
      components: {
        fullscreen: {
          disableDoubleClick: false
        }
      },
      uiComponents: [
        {
          presets: ['Playback', 'Live'],
          area: 'BottomBarRightControls',
          replaceComponent: 'Fullscreen',
          get: kPlayer.ui.components.Remove
        }
      ]
    }
  };

  // Check and add plugins only if they exist
  if (kPlayer.plugins["download"]) {
    config.plugins.download = {
      disable: true    };
  }

  if (kPlayer.plugins["transcript"]) {
    config.plugins["playkit-js-transcript"] = {
      position: "right", // Default: bottom;('left', 'right', 'top', 'bottom') to enable transcript.
      expandMode: "over", // Default: alongside;('alongside', 'hidden', 'over')
      expandOnFirstPlay: false,
      showTime: true,
      downloadDisabled: false,
      printDisabled: false,
      disable: true    };
  }

      if (kPlayer.plugins["preventSeek"]) {
      config.plugins.preventSeek = {
        preventSeekForward: false,
        preventSeek: false      };
    }
    config.plugins.floating = {
      disable: true    };
    if (kPlayer.plugins["navigation"]) {
      config.plugins.navigation = {
        position: "right",
        expandMode: "over",
        expandOnFirstPlay: false,
        visible: false      };
    }
    if (kPlayer.plugins["hotspots"]) {
      config.plugins['playkit-js-hotspots'] = {
        disable: true      };
    }
    if (kPlayer.plugins["moderation"]) {
      config.plugins['playkit-js-moderation'] = {
        disable: true      };
    }
    if (kPlayer.plugins["info"]) {
      config.plugins['playkit-js-info'] = {
        disable: true      };
    }
    if (kPlayer.plugins["share"]) {
      config.plugins.share = {
        disable: true      };
    }
          config.ui.uiComponents = [];
                    if (kPlayer.plugins["googleAnalytics"]) {
      config.plugins.googleTagManager = {};
      config.plugins.googleTagManager.customEventsTracking = {};
      config.plugins.googleTagManager.containerId = 'GTM-57RJQ5';
              config.plugins.googleTagManager.customEventsTracking.custom = [];
                    config.plugins.googleTagManager.customEventsTracking = {
          preset: {
            coreEvents: true,
            UIEvents: false,
            playlistEvents: false,
            castEvents: false
          }
        };
          }
  



 
    // Ensure the global player registry array always exists, regardless of embed type.
    window.kalturaPlayerVideos = window.kalturaPlayerVideos || [];
    try {
              var thumbEmbedPromise = __thumbnailEmbed({config, mediaInfo: {entryId: "1_iixsmm0e"}});
        // __thumbnailEmbed() returns a Promise that resolves with the player instance
        // when the user clicks the thumbnail. Use .then() to capture the player directly.
        thumbEmbedPromise
          .then(function(player) {
            window.kalturaPlayerVideos.push(player);
            // Notify kaltura_datalayer.js that a new player is ready so it can
            // attach custom event listeners immediately, regardless of when
            // the user clicked the thumbnail relative to page load.
            document.dispatchEvent(new CustomEvent('kalturaPlayerReady', { detail: { player: player } }));
          })
          .catch(function(error) {
            console.error(error);
          });
          } catch (e) {
      console.error(e.message)
    }
  

 







 



 [ 

 ![nibr discovery efforts](/in-en/sites/novartis_in/files/styles/cards_1_3/public/2022-06/nibr-discovery-efforts.jpg.webp?itok=AL3Osbav "nibr discovery efforts") 

 

###  Research and Development 

We are an innovative medicines company with research and development at our core. Our R&D engine powers an industry-leading pipeline focused on delivering transformative medicines to fight disease, restore possibility and help people live life on their own terms.

 

 

 ](https://www.novartis.com/research-development/novartis-institutes-biomedical-research) [ 

 ![nibr-lab2lab](/in-en/sites/novartis_in/files/styles/cards_1_3/public/2022-06/nibr-lab2lab.jpg.webp?itok=I9QaR-uF "vial at the lab") 

 

###  How a 19th-century technology is speeding up drug discovery 

Pneumatic tube systems have existed for 150+ years and have transported everything from telegrams to aircraft parts. Now they’re being used in our labs.

 

 

 ](https://www.novartis.com/stories/how-19th-century-technology-speeding-drug-discovery) [ 

 ![cell-processing-specialist](/in-en/sites/novartis_in/files/styles/cards_1_3/public/2022-06/cell-processing-specialist-lab-image.jpg.webp?itok=OUGjJgZ5 "cell-processing-specialist-at-lab") 

 

###  Hardwiring the future 

A Cell & Gene production unit staffed by a highly trained team at Novartis will soon begin operating in Stein, Switzerland.

 

 

 ](https://www.novartis.com/stories/hardwiring-future)